2018
DOI: 10.1289/ehp1289
|View full text |Cite|
|
Sign up to set email alerts
|

A Web-Based System for Bayesian Benchmark Dose Estimation

Abstract: Background:Benchmark dose (BMD) modeling is an important step in human health risk assessment and is used as the default approach to identify the point of departure for risk assessment. A probabilistic framework for dose–response assessment has been proposed and advocated by various institutions and organizations; therefore, a reliable tool is needed to provide distributional estimates for BMD and other important quantities in dose–response assessment.Objectives:We developed an online system for Bayesian BMD (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
90
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 101 publications
(91 citation statements)
references
References 26 publications
1
90
0
Order By: Relevance
“…Moreover, this large number of endpoints and chemicals enabled us to draw general conclusions as to the level of protection implied by current RfDs, extending previous work by Castorina and Woodruff ( 2003 ), the extent that exposure limits based on a probabilistic RfD are likely to differ from current RfDs, and what additional data or analyses could reduce uncertainty in the predicted risks. Finally, we deployed the workflow in two online tools: a standalone web app titled APROBAweb at https://wchiu.shinyapps.io/APROBAweb / ( Chiu 2018a ) and an implementation that could be integrated with Bayesian benchmark dose modeling at https://benchmarkdose.org ( Shao and Shapiro 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, this large number of endpoints and chemicals enabled us to draw general conclusions as to the level of protection implied by current RfDs, extending previous work by Castorina and Woodruff ( 2003 ), the extent that exposure limits based on a probabilistic RfD are likely to differ from current RfDs, and what additional data or analyses could reduce uncertainty in the predicted risks. Finally, we deployed the workflow in two online tools: a standalone web app titled APROBAweb at https://wchiu.shinyapps.io/APROBAweb / ( Chiu 2018a ) and an implementation that could be integrated with Bayesian benchmark dose modeling at https://benchmarkdose.org ( Shao and Shapiro 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…[45] All steps were established under the BMDS guidelines. [46][47][48][49] Multiple models were selected for analysis, including extra risk assumptions for background and a benchmark response of 5%. [33,34] According to the included studies, the dose response was divided into two categories: family economic status in childhood and childhood housing conditions.…”
Section: Quality Assessmentmentioning
confidence: 99%
“…Using data from Tryphonas et al (1991) (summarized in Table S9), we conducted benchmark dose modeling of decreases in immunoglobulin M. This is a sensitive end point, selected based on high statistical significance and relatively large effects reported in the study. We used the web portal benchmarkdose.org (Shao and Shapiro 2018), setting the benchmark response at 50%, a value similar to the lowest observed adverse effect-level for multiple effects reported in the study (Tryphonas et al 1991). To account for model uncertainty, we used Bayesian model averaging (three Markov Chains for eight different models) as described by Shao and Shapiro (2018).…”
Section: Dose-response and Severitymentioning
confidence: 99%
“…We used the web portal benchmarkdose.org (Shao and Shapiro 2018), setting the benchmark response at 50%, a value similar to the lowest observed adverse effect-level for multiple effects reported in the study (Tryphonas et al 1991). To account for model uncertainty, we used Bayesian model averaging (three Markov Chains for eight different models) as described by Shao and Shapiro (2018). The remaining probabilistic extrapolations were conducted following approaches described by Chiu and Slob (2015) and Chiu et al (2018).…”
Section: Dose-response and Severitymentioning
confidence: 99%